To that point, she twice filed amendments designed to free up research into the therapeutic potential of psychedelics that were defeated on the House floor. In 2022, Ocasio-Cortez led a separate NDAA amendment to require DOD to study the therapeutic potential of psilocybin and MDMA for military service members. Rep. Lou Correa (D-CA), meanwhile, told Marijuana Moment last week that he is “hearing a lot about psychedelics.” Correa, who leads the Congressional Psychedelics Advancing Therapies (PATH) Caucus said he faced an internal “conflict” on last week’s vote on the NDAA. The amendment also directs the department to create a workforce implementation-readiness plan for psychedelics and other emerging therapeutic interventions.